Tag: Russian Pharma

WERTEKS Sees Future in Global Markets

Russian manufacturer of drugs and cosmetics, WERTEKS, connects long-term successful cooperation with Chinese partners – the largest suppliers of active pharmaceutical substances and excipients. In par...

Antibacterial Nano-Material Discovered by Novosibirsk Scientists

Researchers at the Institute of Cytology and Genetics (Novosibirsk) have discovered antibacterial properties in a nano-material developed by the Nikolayev Institute of Nonorganic Chemistry. The che...

Peritech Pharma Got Patents in China and Russia

Peritech Pharma, a specialty anal-rectal pharmaceutical company, announced it has been granted patents covering China and Russia for its drug delivery platform used for two of its over-the-counter pro...

Russia in Risk of Drug Shortage

The existing sanctions regime against Russia may lead to the shortage of drugs in the local market over the next several years, according to recent statements by analysts of the Russian Ministry of He...

First Russian Original Therapeutic Monoclonal Antibody is Registered

Biotechnology company BIOCAD registered its original interleukin-17 inhibitor (anti-IL-17) for the treatment of moderate to severe plaque psoriasis. Development and clinical studies of the new drug Ef...

Russian Companies to Scale Up Production of Innovative HIV Drug

Pharmstandard, the leader of the Russian pharmaceutical market, and ChemRar Group, the leading developer of medical products, have combined their efforts to scale up the production of Elpida®, a Russi...

Biokhimik Received Certificate for First Russian Generic Doripenem

ab
JSC "Biokhimik", the leader in the production of antibiotics in the Russian Federation received a registration certificate for the production of the generic Doripenem – the first in the country. This ...

Takeda Completed the Localization of Advate in Russia

Takeda completed the localization of the production of Advate (Octocog alpha) medicine, intended for the treatment of patients with hemophilia A, at the Moscow-based Biocad plant. This was told to Kom...

PopsiCube Opens Strategic Russian Affiliate

CRO PopsiCube opens strategic Russian affiliate to further its international expansion of clinical trial management and digital services. PopsiCube, the digital Clinical Research Organization, prov...

State Duma Reviews Bill on Fines for Selling Meds with Psychoactive Effect

The Federation Council member Irina Rukavishnikova has submitted a bill on fines for violations in selling certain medical products having psychoactive effect to the State Duma. The document has been ...

Consortium of Investors to Support the Creation of Leading Russian Pharmaceutical Holding

A consortium of investors including the Russian Direct Investment Fund (RDIF, Russia’s sovereign wealth fund), the Russia-China Investment Fund (RCIF, established by RDIF and China Investment Corporat...

Russia’s Pharma Market Grew by 1,7% in Q1 2019

pills
The Russian pharmaceutical market continues to see growth. Over the first three months of this year, it grew by 1.7% in ruble terms and reached 255.2 billion rubles, stated DSM Group in its analytical...

Russian Scientists Develop Low-cost Method of Diagnosing Multiple Sclerosis

Researchers at the Krasnoyarsk Research Center of the Russian Academy of Sciences’ Siberian Department together with colleagues from the Institute of Basic Medical Research and Chemical Biology (Novos...

Improving Solutions in Healthcare in Russia

French-Russian Round Table “Partnership in the name of health. Improving solutions and provision in healthcare” was organized in Moscow. The event focused on assessment of healthcare technologies, dev...

Generium to Build Biopharmaceutical Plant Worth 10 Billion Rubles

JSC Generium, a pharmaceutical company integrated with Generium Group, plans to invest 9 billion – 10 billion rubles in the coming five years in a project to augment the production of biopharmaceutica...

Russia Fights with False Information in Medicine Monitoring System

The State Duma adopted in a final third reading on Tuesday (April 9) a bill on fines for untimely entry or import of false information into the medicinal drugs monitoring system. Under the bill, of...